Loading...

Surgery Partners, Inc. Peer Comparison

Metric Value Ranking
Market Cap $3.3 Billion 4/9 UHS
$12.0B
EHC
$10.2B
ENSG
$7.4B
SGRY
$3.3B
SEM
$2.4B
ADUS
$2.1B
PNTG
$890.7M
HCSG
$794.5M
INNV
$458.5M
Gross Margin 23% 5/9 PNTG
100%
UHS
72%
EHC
46%
ADUS
33%
SGRY
23%
INNV
17%
ENSG
16%
HCSG
15%
SEM
11%
Profit Margin -4% 9/9 EHC
9%
UHS
7%
ADUS
7%
ENSG
7%
HCSG
3%
SEM
3%
PNTG
3%
INNV
-2%
SGRY
-4%
EBITDA margin -5% 9/9 SEM
88%
EHC
19%
UHS
13%
ENSG
11%
ADUS
10%
HCSG
5%
PNTG
3%
INNV
1%
SGRY
-5%
Quarterly Revenue $770.4 Million 5/9 UHS
$4.0B
SEM
$1.8B
EHC
$1.4B
ENSG
$1.1B
SGRY
$770.4M
HCSG
$428.1M
ADUS
$289.8M
INNV
$205.1M
PNTG
$180.7M
Quarterly Earnings -$31.7 Million 9/9 UHS
$258.7M
EHC
$120.9M
ENSG
$79.7M
SEM
$55.6M
ADUS
$20.2M
HCSG
$14.0M
PNTG
$6.2M
INNV
-$4.9M
SGRY
-$31.7M
Quarterly Free Cash Flow $45.0 Million 5/9 SEM
$289.0M
UHS
$81.9M
ENSG
$52.3M
ADUS
$46.6M
SGRY
$45.0M
PNTG
$18.2M
HCSG
$2.9M
INNV
-$9.7M
EHC
-$0
Trailing 4 Quarters Revenue $3.0 Billion 5/9 UHS
$15.4B
SEM
$7.0B
EHC
$5.4B
ENSG
$4.2B
SGRY
$3.0B
HCSG
$1.7B
ADUS
$1.1B
INNV
$786.5M
PNTG
$652.3M
Trailing 4 Quarters Earnings -$900,000 8/9 UHS
$4.0B
SEM
$1.8B
EHC
$1.4B
ENSG
$1.1B
SGRY
$770.4M
HCSG
$428.1M
ADUS
$289.8M
INNV
$205.1M
PNTG
$180.7M
Quarterly Earnings Growth -188% 9/9 HCSG
355%
ENSG
267%
UHS
55%
INNV
52%
PNTG
42%
EHC
38%
ADUS
31%
SEM
15%
SGRY
-188%
Annual Earnings Growth -101% 9/9 HCSG
147%
PNTG
66%
INNV
64%
UHS
51%
ENSG
40%
EHC
33%
ADUS
23%
SEM
-3%
SGRY
-101%
Quarterly Revenue Growth 14% 3/9 PNTG
29%
ENSG
15%
SGRY
14%
EHC
13%
INNV
12%
UHS
11%
ADUS
7%
SEM
6%
HCSG
4%
Annual Revenue Growth 12% 2/9 PNTG
21%
SGRY
12%
ENSG
11%
EHC
10%
INNV
10%
UHS
9%
ADUS
8%
SEM
4%
HCSG
2%
Cash On Hand $221.8 Million 3/9 ENSG
$464.6M
ADUS
$222.9M
SGRY
$221.8M
SEM
$191.5M
UHS
$106.1M
EHC
$85.4M
HCSG
$53.2M
INNV
$39.0M
PNTG
$4.5M
Short Term Debt $97.3 Million 5/9 SEM
$292.6M
ENSG
$191.0M
EHC
$164.9M
UHS
$111.2M
SGRY
$97.3M
HCSG
$25.0M
INNV
$23.1M
PNTG
$19.1M
ADUS
$11.2M
Long Term Debt $3.4 Billion 3/9 UHS
$5.0B
SEM
$4.3B
SGRY
$3.4B
ENSG
$1.7B
PNTG
$357.8M
EHC
$189.7M
INNV
$96.5M
ADUS
$38.6M
HCSG
$9.0M
PE -1.00 8/9 PNTG
42.11
ADUS
27.88
ENSG
24.68
EHC
22.30
HCSG
15.84
UHS
11.67
SEM
8.84
SGRY
-1.00
INNV
-1.00
PS 1.10 5/9 EHC
1.89
ADUS
1.81
ENSG
1.74
PNTG
1.37
SGRY
1.10
UHS
0.78
INNV
0.58
HCSG
0.47
SEM
0.35
PB 1.73 6/9 PNTG
4.76
ENSG
4.00
EHC
3.57
ADUS
2.17
UHS
1.79
SGRY
1.73
HCSG
1.63
INNV
1.58
SEM
1.05
PC 14.83 6/9 PNTG
199.52
EHC
118.99
UHS
112.87
ENSG
15.83
HCSG
14.93
SGRY
14.83
SEM
12.61
INNV
11.75
ADUS
9.21
Liabilities to Equity 2.97 2/9 SEM
2.98
SGRY
2.97
PNTG
2.71
ENSG
1.54
EHC
1.32
UHS
1.15
INNV
0.91
HCSG
0.65
ADUS
0.22
ROA 0.00 8/9 UHS
7%
EHC
7%
HCSG
6%
ADUS
6%
ENSG
6%
SEM
3%
PNTG
3%
SGRY
0%
INNV
-3%
ROE 0.00 8/9 EHC
16%
ENSG
16%
UHS
15%
SEM
14%
PNTG
12%
HCSG
10%
ADUS
8%
SGRY
0%
INNV
-6%
Current Ratio 1.34 9/9 ADUS
5.62
HCSG
2.54
INNV
2.23
UHS
1.87
EHC
1.77
ENSG
1.65
PNTG
1.41
SEM
1.40
SGRY
1.34
Quick Ratio 0.04 5/9 PNTG
42.11
ADUS
27.88
ENSG
24.68
EHC
22.30
HCSG
15.84
UHS
11.67
SEM
8.84
SGRY
-1.00
INNV
-1.00
Long Term Debt to Equity 1.78 3/9 SEM}
2.23
PNTG}
2.11
SGRY}
1.78
ENSG}
0.94
UHS}
0.75
INNV}
0.37
EHC}
0.07
ADUS}
0.04
HCSG}
0.02
Debt to Equity 1.83 3/9 SEM
2.38
PNTG
2.23
SGRY
1.83
ENSG
1.07
UHS
0.76
INNV
0.42
EHC
0.13
HCSG
0.07
ADUS
0.05
Burn Rate 1.16 3/9 ENSG
12.39
INNV
2.68
SGRY
1.16
SEM
1.02
PNTG
0.35
EHC
-1.18
UHS
-3.41
HCSG
-7.17
ADUS
-14.08
Cash to Cap 0.07 4/9 ADUS
0.11
INNV
0.09
SEM
0.08
SGRY
0.07
HCSG
0.07
ENSG
0.06
UHS
0.01
EHC
0.01
PNTG
0.01
CCR -1.42 8/9 SEM
5.20
PNTG
2.93
ADUS
2.31
INNV
1.97
ENSG
0.66
UHS
0.32
HCSG
0.21
SGRY
-1.42
EHC
EV to EBITDA -181.79 9/9 INNV}
393.03
PNTG}
205.05
ENSG}
70.38
ADUS}
65.96
EHC}
38.70
HCSG}
34.33
UHS}
32.11
SEM}
4.37
SGRY}
-181.79
EV to Revenue 2.19 1/9 SGRY
2.19
ENSG
2.09
EHC
1.94
PNTG
1.94
ADUS
1.66
UHS
1.10
SEM
0.97
INNV
0.67
HCSG
0.46